Validation of the Pedigree Assessment Tool (PAT) in Families with BRCA1 and BRCA2 Mutations

Zwaagstra A(1998)Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2 Am J Hum Genet 62 145-715

Ranz M(2004)A breast cancer prediction model incorporating familial and personal risk factors Stat Med 23 1111-54

Domchek SM(2001)Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic J Clin Oncol 19 2247-425

Eisen A(2008)Selecting a BRCA risk assessment model for use in a familial cancer clinic BMC Med Genet. 9 116-406

Calzone K(2002)Model-based predictions of the BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center Cancer 94 305-361

Frank TS(2006)Optimal selection of individuals for BRCA mutation testing: a comparison of available models J Clin Oncol 24 707-undefined

Deffenbaugh AM(2006)Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software Eur J Hum Genet. 14 49-undefined

Reid JE(2008)Breast cancer risk in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation Br J Cancer 100 421-undefined

Harrell FE(2003)Oncology policy statement update: genetic testing for cancer susceptibility J Clin Oncol. 21 2397-undefined

Califf RM(2005)Genetic risk assessment and Ann Intern Med 143 355-undefined

Zwaagstra A(1998)Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2 Am J Hum Genet 62 145-715

Ranz M(2004)A breast cancer prediction model incorporating familial and personal risk factors Stat Med 23 1111-54

Domchek SM(2001)Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic J Clin Oncol 19 2247-425

Eisen A(2008)Selecting a BRCA risk assessment model for use in a familial cancer clinic BMC Med Genet. 9 116-406

Calzone K(2002)Model-based predictions of the BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center Cancer 94 305-361

Frank TS(2006)Optimal selection of individuals for BRCA mutation testing: a comparison of available models J Clin Oncol 24 707-undefined

Deffenbaugh AM(2006)Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software Eur J Hum Genet. 14 49-undefined

Reid JE(2008)Breast cancer risk in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation Br J Cancer 100 421-undefined

Harrell FE(2003)Oncology policy statement update: genetic testing for cancer susceptibility J Clin Oncol. 21 2397-undefined

Califf RM(2005)Genetic risk assessment and Ann Intern Med 143 355-undefined